Endoscopic Stenting of Dominant Strictures in Patients with Primary Sclerosing Cholangitis: When, How, and for How Long?

Overview

Journal Endosc Int Open

Specialty Gastroenterology

Date 2022 Sep 19

PMID 36118640

Authors

Il Sang Shin

Jong Ho Moon

Affiliations

Soon will be listed here.

References

Gluck M, Cantone N, Brandabur J, Patterson D, Bredfeldt J, Kozarek R . A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis. J Clin Gastroenterol. 2008; 42(9):1032-9. DOI: 10.1097/MCG.0b013e3181646713. View

Ilyas S, Eaton J, Gores G . Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clin Gastroenterol Hepatol. 2015; 13(12):2152-65. PMC: 4618039. DOI: 10.1016/j.cgh.2015.05.035. View

Ponsioen C, Lam K, van Milligen de Wit A, Huibregtse K, Tytgat G . Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol. 1999; 94(9):2403-7. DOI: 10.1111/j.1572-0241.1999.01364.x. View

Dyson J, Beuers U, Jones D, Lohse A, Hudson M . Primary sclerosing cholangitis. Lancet. 2018; 391(10139):2547-2559. DOI: 10.1016/S0140-6736(18)30300-3. View

Ponsioen C, Arnelo U, Bergquist A, Rauws E, Paulsen V, Cantu P . No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis. Gastroenterology. 2018; 155(3):752-759.e5. DOI: 10.1053/j.gastro.2018.05.034. View

Ismail S, Kylanpaa L, Mustonen H, Halttunen J, Lindstrom O, Jokelainen K . Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy. 2012; 44(12):1133-8. DOI: 10.1055/s-0032-1325677. View

Aabakken L, Karlsen T, Albert J, Arvanitakis M, Chazouilleres O, Dumonceau J . Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017; 49(6):588-608. DOI: 10.1055/s-0043-107029. View

Ferreira M, Ribeiro I, Hourneaux de Moura D, McCarty T, da Ponte Neto A, Farias G . Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis. Clin Endosc. 2021; 54(6):833-842. PMC: 8652153. DOI: 10.5946/ce.2021.052. View

van Milligen de Wit A, Rauws E, van Bracht J, Mulder C, Jones E, Tytgat G . Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc. 1997; 46(4):344-7. DOI: 10.1016/s0016-5107(97)70123-8. View

10.

Sbeit W, Khoury T, Goldin E, Mahamid M . Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety. Surg Endosc. 2021; 36(4):2412-2417. DOI: 10.1007/s00464-021-08522-x. View

11.

Kaya M, Petersen B, Angulo P, Baron T, Andrews J, Gostout C . Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol. 2001; 96(4):1059-66. DOI: 10.1111/j.1572-0241.2001.03690.x. View

12.

Lazaridis K, LaRusso N . Primary Sclerosing Cholangitis. N Engl J Med. 2016; 375(12):1161-70. PMC: 5553912. DOI: 10.1056/NEJMra1506330. View

13.

Gotthardt D, Rudolph G, Kloters-Plachky P, Kulaksiz H, Stiehl A . Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. Gastrointest Endosc. 2010; 71(3):527-34. DOI: 10.1016/j.gie.2009.10.041. View